Clinical effect of omalizumab as an adjuvant treatment to rituximab in patient with refractory bullous pemphigoid. Kwon IJ, Kim T, Yoo DS, Min S, et al. J Dermatol 2023;50:705-709.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kwon IJ, Kim T, Yoo DS, Min S, et al. Clinical effect of omalizumab as an adjuvant treatment to rituximab in patient with refractory bullous pemphigoid. J Dermatol 2023;50:705-709.
PMID: 36514846